These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27785036)

  • 1. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.
    Peters-Strickland T; Pestreich L; Hatch A; Rohatagi S; Baker RA; Docherty JP; Markovtsova L; Raja P; Weiden PJ; Walling DP
    Neuropsychiatr Dis Treat; 2016; 12():2587-2594. PubMed ID: 27785036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.
    Kopelowicz A; Baker RA; Zhao C; Brewer C; Lawson E; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2017; 13():2641-2651. PubMed ID: 29089771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
    Fowler JC; Cope N; Knights J; Phiri P; Makin A; Peters-Strickland T; Rathod S
    BMJ Open; 2019 Jun; 9(6):e025952. PubMed ID: 31253613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis.
    Fowler JC; Cope N; Knights J; Fang H; Skubiak T; Shergill SS; Phiri P; Rathod S; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2021; 17():483-492. PubMed ID: 33603385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period.
    Profit D; Rohatagi S; Zhao C; Hatch A; Docherty JP; Peters-Strickland TS
    J Clin Psychiatry; 2016 Sep; 77(9):e1095-e1100. PubMed ID: 27379966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital Medicine System in Veterans With Severe Mental Illness: Feasibility and Acceptability Study.
    Gonzales S; Okusaga OO; Reuteman-Fowler JC; Oakes MM; Brown JN; Moore S; Lewinski AA; Rodriguez C; Moncayo N; Smith VA; Malone S; List J; Cho RY; Jeffreys AS; Bosworth HB
    JMIR Form Res; 2022 Dec; 6(12):e34893. PubMed ID: 36548028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia.
    Cochran JM; Fang H; Sonnenberg JG; Cohen EA; Lindenmayer JP; Reuteman-Fowler JC
    Neuropsychiatr Dis Treat; 2022; 18():1521-1534. PubMed ID: 35928793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a Digital Medicine System in Psychiatry.
    Rohatagi S; Profit D; Hatch A; Zhao C; Docherty JP; Peters-Strickland TS
    J Clin Psychiatry; 2016 Sep; 77(9):e1101-e1107. PubMed ID: 27487251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia.
    Cochran JM; Fang H; Le Gallo C; Peters-Strickland T; Lindenmayer JP; Reuteman-Fowler JC
    Patient Prefer Adherence; 2022; 16():1805-1817. PubMed ID: 35923658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
    Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
    J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study.
    Flores GP; Peace B; Carnes TC; Baumgartner SL; Buffkin DE; Euliano NR; Smith LN
    Innov Clin Neurosci; 2016; 13(9-10):12-19. PubMed ID: 27974996
    [No Abstract]   [Full Text] [Related]  

  • 12. Human factors evaluation of a novel digital medicine system in psychiatry.
    Peters-Strickland T; Hatch A; Adenwala A; Atkinson K; Bartfeld B
    Neuropsychiatr Dis Treat; 2018; 14():553-565. PubMed ID: 29497299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
    Kerwin R; Millet B; Herman E; Banki CM; Lublin H; Pans M; Hanssens L; L'Italien G; McQuade RD; Beuzen JN
    Eur Psychiatry; 2007 Oct; 22(7):433-43. PubMed ID: 17555947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia.
    Cohen EA; Skubiak T; Hadzi Boskovic D; Norman K; Knights J; Fang H; Coppin-Renz A; Peters-Strickland T; Lindenmayer JP; Reuteman-Fowler JC
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35421287
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
    Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
    CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
    Tandon R; Marcus RN; Stock EG; Riera LC; Kostic D; Pans M; McQuade RD; Nyilas M; Iwamoto T; Crandall DT
    Schizophr Res; 2006 May; 84(1):77-89. PubMed ID: 16483745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.
    Hsieh MH; Lin WW; Chen ST; Chen KC; Chen KP; Chiu NY; Huang C; Chang CJ; Lin CH; Lai TJ
    Ann Gen Psychiatry; 2010 Sep; 9():35. PubMed ID: 20849577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
    Potkin SG; Loze JY; Forray C; Baker RA; Sapin C; Peters-Strickland T; Beillat M; Nylander AG; Hertel P; Nitschky Schmidt S; Eramo A; Hansen K; Naber D
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):40-49. PubMed ID: 27927736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.